Approval · Notice of Compliance 36864 · 2026
PANHEMATIN: Notice of Compliance 36864
Issued February 6, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36864
- Date
- February 6, 2026
- Company
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PANHEMATIN | Not yet assigned | — |
Medicinal ingredients
- HEMIN 268 MG per VIAL